University of Rochester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rochester sits in the top decile of US sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count).
University of Rochester: 636 sponsored US clinical trials, 94 recruiting.
University of Rochester sponsors 636 registered US clinical trials on ClinicalTrials.gov, 94 of them currently recruiting, and 448 completed. 54 of these trials are in Phase 3-4 (later-stage) and 147 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 7 trials.
Top-decile sponsor footprint
University of Rochester ranks in the top decile of sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
448 of 506 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
636 total, page 10 of 13
Open-Label Trial Comparing Oxycodone Medications
NCT01162304
The Effect of Interoperable Health IT on Efficiency in Ambulatory Practices
NCT01773577
A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT00861874
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
NCT01023711
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine
NCT01023776
Bowel Function After Minimally Invasive Urogynecologic Surgery
NCT01044212
Robotic Urogynecological Surgery: Hospital Stay and Perioperative Complications
NCT01033786
A Pilot Study to Improve Preventive Asthma Care for Urban Adolescents
NCT01106326
Automated Device for Asthma Monitoring
NCT01696357
Bioavailability of Ubiquinol in Huntington Disease
NCT00980694
An Evaluation of the Energy Expenditure From Wii Fit Games
NCT01561716
Phamacological Reversal of Airway Instability During Sedation
NCT01171118
The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention
NCT01532934
Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
NCT01083563
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
NCT00876915
Self Management in Urinary Catheter Users
NCT00883220
Macular Degeneration and Aging Study
NCT02224963
Iron Status and Myelination in Premature Infants
NCT00684697
The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)
NCT00851669
Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases
NCT00904553
Upper Airway Physical Therapy for the Treatment of Obstructive Sleep Apnea
NCT02109731
Perinatal Depression Treatment in a Pediatric Setting- Pilot Phase
NCT00804739
Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD
NCT00624546
Calcitriol, Physical Activity, and Bone Health in Cancer Survivors
NCT00904033
Effects of Pioglitazone on Platelet Function
NCT00861341
Diabetes Prevention Program Pilot Study
NCT00729079
Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome
NCT00839501
Eliminate Risk of Cardiac Surgical Site Events
NCT01425697
Newborn Health Information Study
NCT00820677
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
NCT00771914
Burden of Cancer in Children: A Pilot Study to Investigate the Impact and Content of Video Illness Narratives
NCT00793299
A Multifaceted Prompting Intervention for Urban Children With Asthma
NCT01105754
Atomoxetine, Placebo and Parent Management Training in Autism
NCT00844753
Examining the Relationship Between Tobacco Exposure, Abdominal Obesity, and Metabolic Syndrome in Adolescents (The STRONG Kids Study)
NCT00808158
Lateral Ankle Sprain Study
NCT00761865
Communication Intervention Physical Activity
NCT01419093
S-100B as Pre-Head CT Scan Screening Test After Mild Traumatic Brain Injury
NCT00717301
Uroflow Measurements in Urogynecology Patients Compared to Healthy Female Volunteers
NCT00919048
Evaluation of Postoperative Blood Pressure Changes After Benign Gynecologic Surgery
NCT00757484
Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women
NCT00745368
Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma
NCT00903890
Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
NCT00714792
Information Processing at Sleep Onset and During Sleep in Patients With Insomnia
NCT00680199
Gene Expression In Pregnancies Complicated by Preeclampsia
NCT00919360
Epidemiology of Depression, Anxiety, and Cognitive Impairment
NCT00717041
Forensic Assertive Community Treatment: An Emerging Model of Service Delivery
NCT01313052
Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population
NCT00668551
The Psychoneuroimmunology of Insomnia
NCT00680771
Lumbar Stenosis Outcomes Research (LUSTOR)
NCT00638443
Lumbar Stenosis Outcomes Research II
NCT00652093
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 66 |
| Phase 2 | 81 |
| Phase 3 | 20 |
| Phase 4 | 34 |
Therapeutic Areas
What is open in the University of Rochester pipeline
94 recruiting of 636 indexed (15% open); 448 completed (70%).
Phase mix: 54 late (III/IV) vs 147 early (I/II) (early-phase heavy).
Top condition: Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rochester: open-pipeline peers nationwide
Peers matched on 636 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Rochester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 636 trials (± recruiting share)
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Southern California · 617 trials · 16% recruiting
- Baylor College of Medicine · 616 trials · 15% recruiting
- University of California, Davis · 657 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Loma Linda University · 15% recruiting · 237 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this University of Rochester page
636 registered trials is a research-attention snapshot, not an endorsement of University of Rochester or any single study.
- 94 of University of Rochester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of Rochester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Rochester pipeline card: 636 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.